Literature DB >> 8127568

Idiopathic recurrent branch retinal arterial occlusion. Natural history and laboratory evaluation.

M W Johnson1, M L Thomley, S S Huang, J D Gass.   

Abstract

PURPOSE: To investigate the long-term visual and systemic prognosis of patients with idiopathic recurrent branch retinal artery occlusions, and to test recent hypotheses regarding possible causes of this syndrome.
METHODS: The authors retrospectively reviewed the medical and photographic records of 16 eligible patients. Each of 15 living patients was interviewed by one of the authors, then underwent follow-up ophthalmic examination, formal visual field testing, and a battery of clinical laboratory tests.
RESULTS: Over a mean follow-up of 9 years, only three eyes (9%) lost visual acuity from foveal ischemia, although nine eyes (28%) had central and/or extensive peripheral visual field loss at final examination. Ocular neovascular complications developed in eight eyes (25%). Eight patients (50%) had associated vestibuloauditory and/or transient sensorimotor symptoms, but serious permanent neurologic deficits or recurrent systemic thromboembolic events did not develop. Although most patients had one or more vaso-occlusive risk factors, extensive laboratory testing failed to define the etiology of the arterial occlusions.
CONCLUSIONS: On long-term follow-up, the visual, neurologic, and systemic prognosis for most patients with idiopathic recurrent branch retinal arterial occlusions remains favorable. Although it is probable that such patients are etiologically heterogeneous, the authors theorize that many have mild or partial manifestations of the microangiopathic syndrome of encephalopathy, hearing loss, and retinal arteriolar occlusions.

Entities:  

Mesh:

Year:  1994        PMID: 8127568     DOI: 10.1016/s0161-6420(94)31309-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Treatment of Susac Syndrome.

Authors:  Ivana Vodopivec; Sashank Prasad
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

2.  Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study.

Authors:  C D Kalogeropoulos; P Spyrou; M I Stefaniotou; E E Tsironi; A A Drosos; K G Psilas
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

3.  Acute retinal arterial occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2011-05-19       Impact factor: 21.198

4.  Differential diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

Review 5.  A clinical approach to the diagnosis of retinal vasculitis.

Authors:  Ahmed M Abu El-Asrar; Carl P Herbort; Khalid F Tabbara
Journal:  Int Ophthalmol       Date:  2009-02-04       Impact factor: 2.031

Review 6.  Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice.

Authors:  Amre Nouh; Mohammed Hussain; Tapan Mehta; Shadi Yaghi
Journal:  Front Neurol       Date:  2016-03-21       Impact factor: 4.003

7.  Branch retinal artery occlusion - Finding the culprit!

Authors:  B Poornachandra; Karen Sharma; Neha Peraka Sudhakar; Santosh Gopi Krishna Gadde; Chaitra Jayadev
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

8.  Idiopathic retinal arterial occlusive vasculitis in the setting of multiple arterial occlusions.

Authors:  Patrick Wang; Eric K Chin; David Rp Almeida
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-08

9.  Sequential Presentation of Superior and Inferior Branch Retinal Artery Occlusion in the Same Eye.

Authors:  Berrak Sekeryapan Gediz; Mehmet Ali Sekeroglu
Journal:  Beyoglu Eye J       Date:  2020-12-28

10.  Migration of segmental arteriolar fluorescein staining peripherally in eye with idiopathic recurrent branch retinal arterial occlusion.

Authors:  Kenichi Kawano; Yasuki Ito; Fuminori Haga; Taichi Tsunekawa; Hiroko Terasaki
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.